earnings
JU
NASDAQ · JUNS
Jupiter Neurosciences, Inc.
Healthcare · Biotechnology
$2.05
Up+$0.26 (+12.68%)
Updated Nov 2, 2026, 10:15 PM
SID Score
4.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 41.02M
- P/E ratio
- -5.33
- Dividend yield
- 0.00%
- 52-week range
- $0.08 – $11.20
- Volume
- 18.03K
- Avg. volume
- 119.55K
Price performance · JUNS
JUNS price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
JUNS closed at $2.05 after 20 trading sessions, down 15.29% for the selected period.
- Last close
- $2.05
- Period change
- -15.29%
- Period low
- $2.05
- Period high
- $3.36
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $2.40 | $2.41 | $2.05 | $2.05 | 18.03K |
| Oct 29, 2026 | $2.56 | $2.56 | $2.36 | $2.37 | 7.41K |
| Oct 28, 2026 | $2.62 | $2.70 | $2.40 | $2.50 | 29.72K |
| Oct 27, 2026 | $2.86 | $2.91 | $2.64 | $2.64 | 41.72K |
| Oct 26, 2026 | $3.00 | $3.0098 | $2.7174 | $2.86 | 12.9K |
| Oct 23, 2026 | $2.58 | $3.22 | $2.58 | $2.98 | 19.82K |
| Oct 22, 2026 | $2.80 | $2.80 | $2.551 | $2.58 | 10.28K |
| Oct 21, 2026 | $2.78 | $2.80 | $2.6314 | $2.78 | 28.68K |
| Oct 20, 2026 | $2.75 | $3.24 | $2.75 | $2.80 | 11.22K |
| Oct 19, 2026 | $2.77 | $2.82 | $2.75 | $2.75 | 8.49K |
| Oct 16, 2026 | $3.09 | $3.1152 | $2.8806 | $2.905 | 13.92K |
| Oct 15, 2026 | $3.16 | $3.27 | $3.025 | $3.14 | 19.81K |
| Oct 14, 2026 | $3.30 | $3.43 | $3.07 | $3.19 | 20.93K |
| Oct 13, 2026 | $3.00 | $3.4999 | $3.00 | $3.36 | 71.54K |
| Oct 12, 2026 | $2.89 | $3.04 | $2.7604 | $3.04 | 37.24K |
| Oct 9, 2026 | $2.83 | $2.89 | $2.67 | $2.85 | 7.04K |
| Oct 8, 2026 | $2.70 | $2.8499 | $2.6604 | $2.77 | 36.89K |
| Oct 7, 2026 | $2.61 | $2.8579 | $2.5801 | $2.84 | 47.08K |
| Oct 6, 2026 | $2.38 | $3.18 | $2.251 | $2.86 | 927.42K |
| Oct 5, 2026 | $2.425 | $2.55 | $2.3301 | $2.42 | 14.94K |
Latest JUNS news
The latest Smart Investors Daily articles mentioning JUNS.
Stock researchResearch & News · SEC Filings
Company
Market Activity
Research & News
Loading stock research…